Dyne Therapeutics Inc. News, Dyne Therapeutics Inc. Quote, DYN Quote

Dyne Therapeutics Inc. (NQ:DYN) Delayed: 17.99 +0.75 (4.35%)

Prev. Close

$17.24

Today 6M 1Y 5Y

Open

$17.25

52 Wk High

$22.01

52 Wk Low

$7.01

Day High

$18.07

Day Low

$17.19

P/E

N/A

EPS

$0.00

Volume

1,556,901

Friends, Peers and Foes (?): RNA, XENE, VRTX, ACAD, BCRX (more...)

ALERTS | RSS

Jun 3, 2026 07:35 AM Form 8-K Dyne Therapeutics, Inc. For: Jun 03
Jun 3, 2026 07:30 AM Dyne Therapeutics completes enrollment in myotonic dystrophy trial
Jun 3, 2026 07:30 AM Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)
May 28, 2026 04:56 PM Form 4 Dyne Therapeutics, Inc. For: May 26 Filed by: Posner Brian S
May 26, 2026 07:31 AM Dyne Therapeutics submits FDA application for DMD treatment
May 26, 2026 07:30 AM Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
May 22, 2026 04:10 PM Form 4 Dyne Therapeutics, Inc. For: May 20 Filed by: Posner Brian S
May 20, 2026 05:30 PM Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 20, 2026 05:30 PM Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 20, 2026 07:46 AM Dyne starts phase 3 trial of muscular dystrophy drug z-rostudirsen

Entities mentioned with DYN

View All Entities